T1	DISO 78 102	síndrome de Prader-Willi
#1	AnnotatorNotes T1	C0032897; Prader-Willi Syndrome; Disease or Syndrome
T2	PROC 139 150	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	CHEM 155 178	hormona del crecimiento
#3	AnnotatorNotes T3	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T4	PROC 283 301	técnicas de imagen
#4	AnnotatorNotes T4	C0079595; Imaging Techniques; Diagnostic Procedure
T5	PROC 324 335	Tratamiento
#5	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	CHEM 340 362	hormona de crecimiento
#6	AnnotatorNotes T6	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T7	DISO 380 404	Síndrome de Prader-Willi
#7	AnnotatorNotes T7	C0032897; Prader-Willi Syndrome; Disease or Syndrome
T8	PROC 486 489	RMf
T9	PROC 454 484	resonancia magnética funcional
#8	AnnotatorNotes T9	C0412677; MRI of brain with functional imaging; Diagnostic Procedure
T10	DISO 590 614	síndrome de Prader-Willi
#9	AnnotatorNotes T10	C0032897; Prader-Willi Syndrome; Disease or Syndrome
T11	CHEM 630 652	hormona de crecimiento
#10	AnnotatorNotes T11	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T12	CHEM 765 767	GH
#11	AnnotatorNotes T12	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T13	CHEM 820 822	GH
#12	AnnotatorNotes T13	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T14	CHEM 904 906	GH
#13	AnnotatorNotes T14	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T15	CHEM 919 921	GH
#14	AnnotatorNotes T15	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T16	CHEM 952 956	GHRH
#15	AnnotatorNotes T16	C0037668; Somatotropin-Releasing Hormone; Amino Acid, Peptide, or Protein · Hormone
T17	CHEM 958 966	arginina
#16	AnnotatorNotes T17	C0003765; arginine; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T18	CHEM 1093 1095	GH
#17	AnnotatorNotes T18	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T19	PROC 1102 1137	prueba de estimulación con glucagón
#18	AnnotatorNotes T19	C0430186; Glucagon stimulation test; Laboratory Procedure
T20	PROC 1255 1279	consentimiento informado
#19	AnnotatorNotes T20	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T21	DISO 1595 1610	Obesidad severa
#20	AnnotatorNotes T21	C2874225; Morbid (severe) obesity due to excess calories; Disease or Syndrome
T22	DISO 1612 1620	diabetes
#21	AnnotatorNotes T22	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T23	PROC 1522 1525	RMf
T24	DISO 1636 1669	apnea obstructiva grave del sueño
T25	DISO 1682 1688	cáncer
#22	AnnotatorNotes T25	C0006826; Malignant Neoplasms; Neoplastic Process
T26	DISO 1698 1706	psicosis
#23	AnnotatorNotes T26	C0033975; Psychotic Disorders; Mental or Behavioral Dysfunction
T27	CHEM 1801 1803	GH
#24	AnnotatorNotes T27	C0037663; Growth Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C0169964; somatropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T28	PROC 1995 2007	valoraciones
#25	AnnotatorNotes T28	C1261322; Evaluation procedure; Health Care Activity
T29	ANAT 193 201	muscular
#26	AnnotatorNotes T29	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T30	ANAT 230 238	muscular
#27	AnnotatorNotes T30	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T31	ANAT 256 264	corporal
#28	AnnotatorNotes T31	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T32	ANAT 427 435	muscular
#29	AnnotatorNotes T32	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T33	ANAT 519 527	muscular
#30	AnnotatorNotes T33	C0026845; Muscle Tissue; Tissue | C4083049; Muscle (organ); Body Part, Organ, or Organ Component
T34	ANAT 545 553	corporal
#31	AnnotatorNotes T34	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T35	DISO 619 652	déficit de hormona de crecimiento
T36	DISO 754 767	déficit de GH
T37	PROC 1012 1015	IMC
#32	AnnotatorNotes T37	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T38	PROC 797 822	pruebas de estímulo de GH
#33	AnnotatorNotes T38	C0373506; Growth hormone stimulation test; Laboratory Procedure
T39	PROC 840 856	práctica clínica
T40	DISO 695 698	SPW
T41	DISO 893 906	déficit de GH
T42	PROC 1020 1023	IMC
#34	AnnotatorNotes T42	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T43	PROC 1041 1044	IMC
#35	AnnotatorNotes T43	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T44	PROC 925 966	prueba de estimulación con GHRH+ arginina
T45	PROC 1062 1065	IMC
#36	AnnotatorNotes T45	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T46	PROC 1454 1457	RMf
T47	CHEM 1129 1137	glucagón
#37	AnnotatorNotes T47	C0017687; glucagon; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T48	PROC 1673 1680	tratada
#38	AnnotatorNotes T48	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T49	PROC 1785 1796	tratamiento
#39	AnnotatorNotes T49	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T50	PROC 1589 1592	RMf
T51	Date 12 16	2017
T52	LIVB 56 73	pacientes adultos
#40	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T54	PHYS 188 201	tono muscular
#41	AnnotatorNotes T54	C0026841; Muscle Tonus; Organ or Tissue Function
T55	PHYS 223 238	fuerza muscular
#42	AnnotatorNotes T55	C0517349; Muscle Strength; Organ or Tissue Function
T57	LIVB 369 375	adulto
#43	AnnotatorNotes T57	C0001675; Adult; Age Group
T58	PHYS 422 435	tono muscular
#44	AnnotatorNotes T58	C0026841; Muscle Tonus; Organ or Tissue Function
T59	PHYS 512 527	fuerza muscular
#45	AnnotatorNotes T59	C0517349; Muscle Strength; Organ or Tissue Function
T61	LIVB 576 585	Pacientes
#46	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	LIVB 681 690	Pacientes
#47	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	Age 699 708	≥ 18 años
T64	LIVB 711 720	Pacientes
#48	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T66	Age 970 982	18 a 25 años
T67	Age 996 1004	>25 años
T68	LIVB 1150 1159	Pacientes
#49	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T70	LIVB 1329 1338	pacientes
#50	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T73	Neg_cue 1528 1544	Imposibilidad de
T75	PHYS 1664 1669	sueño
#51	AnnotatorNotes T75	C0037313; Sleep; Organism Function
T76	Neg_cue 1670 1672	no
T77	LIVB 1716 1725	Pacientes
#52	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T78	LIVB 1873 1879	médico
#53	AnnotatorNotes T78	C0031831; Physicians; Professional or Occupational Group
T80	LIVB 1948 1956	paciente
#54	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group
T81	PHYS 167 178	crecimiento
#55	AnnotatorNotes T81	C0018270; Growth; Organism Function
T82	PHYS 351 362	crecimiento
#56	AnnotatorNotes T82	C0018270; Growth; Organism Function
T83	PHYS 641 652	crecimiento
#57	AnnotatorNotes T83	C0018270; Growth; Organism Function
T53	LIVB 1167 1182	tutores legales
#58	AnnotatorNotes T53	C0023226; Legal Guardians; Population Group
T56	PHYS 1545 1553	entender
#59	AnnotatorNotes T56	C0162340; Comprehension; Mental Process
A1	Population_data T52 Age
A2	Population_data T57 Age
A3	Assertion T56 Negated
A4	Assertion T48 Negated
A5	Assertion T46 Contraindicated
A6	Assertion T49 Contraindicated
A7	Assertion T27 Contraindicated
#60	AnnotatorNotes T8	C0412677; MRI of brain with functional imaging; Diagnostic Procedure
#61	AnnotatorNotes T46	C0412677; MRI of brain with functional imaging; Diagnostic Procedure
#62	AnnotatorNotes T23	C0412677; MRI of brain with functional imaging; Diagnostic Procedure
#63	AnnotatorNotes T50	C0412677; MRI of brain with functional imaging; Diagnostic Procedure
#64	AnnotatorNotes T40	C0032897; Prader-Willi Syndrome; Disease or Syndrome
#65	AnnotatorNotes T24	C5562969; Obstructive sleep apnea, severe; Finding
T60	Neg_cue 1621 1623	no
T65	Quantifier_or_Qualifier 1624 1634	controlada
A8	Assertion T65 Negated
T69	Neg_cue 1461 1477	Imposibilidad de
T71	Observation 1478 1492	estarse quieto
A9	Assertion T71 Negated
R1	Negation Arg1:T69 Arg2:T71	
R2	Overlap Arg1:T71 Arg2:T23	
R3	Negation Arg1:T73 Arg2:T56	
T72	PROC 1557 1566	paradigma
#66	AnnotatorNotes T72	C0681797; paradigm; Research Activity (?)
R4	Overlap Arg1:T56 Arg2:T72	
R5	Overlap Arg1:T72 Arg2:T50	
R6	Negation Arg1:T60 Arg2:T65	
R7	Negation Arg1:T76 Arg2:T48	
T74	Spec_cue 1883 1888	pueda
T79	Observation 1900 1906	riesgo
A10	Assertion T79 Speculated
R8	Speculation Arg1:T74 Arg2:T79	
T84	Observation 1909 1926	perjuicio clínico
A11	Assertion T84 Speculated
R9	Speculation Arg1:T74 Arg2:T84	
T85	CONC 1977 1987	interfiera
A12	Assertion T85 Speculated
#67	AnnotatorNotes T85	C0521102; Interferes with; Functional Concept
R10	Speculation Arg1:T74 Arg2:T85	
T86	Observation 1930 1956	participación del paciente
#68	AnnotatorNotes T86	C1278516; Patient participation status; Finding
R11	Overlap Arg1:T84 Arg2:T86	
R12	Overlap Arg1:T79 Arg2:T86	
T87	PHYS 244 264	composición corporal
#69	AnnotatorNotes T87	C0005885; Body Composition; Organism Attribute
R13	Location_of Arg1:T31 Arg2:T87	
T88	PHYS 533 553	composición corporal
#70	AnnotatorNotes T88	C0005885; Body Composition; Organism Attribute
R14	Experiences Arg1:T52 Arg2:T1	
T89	Observation 128 134	efecto
#71	AnnotatorNotes T89	C1518681; Outcome of Therapy; Finding (?)
R15	Causes Arg1:T2 Arg2:T89	
T90	Observation 406 412	efecto
#72	AnnotatorNotes T90	C1518681; Outcome of Therapy; Finding (?)
R16	Causes Arg1:T5 Arg2:T90	
R17	Used_for Arg1:T3 Arg2:T2	
R18	Experiences Arg1:T52 Arg2:T89	
R19	Experiences Arg1:T52 Arg2:T2	
R20	Experiences Arg1:T52 Arg2:T54	
R21	Experiences Arg1:T52 Arg2:T81	
R25	Location_of Arg1:T29 Arg2:T54	
R26	Location_of Arg1:T30 Arg2:T55	
R27	Experiences Arg1:T52 Arg2:T55	
R28	Experiences Arg1:T52 Arg2:T87	
R29	Experiences Arg1:T52 Arg2:T4	
R33	Used_for Arg1:T6 Arg2:T5	
R34	Experiences Arg1:T57 Arg2:T5	
R35	Experiences Arg1:T57 Arg2:T7	
R36	Experiences Arg1:T57 Arg2:T90	
R37	Experiences Arg1:T57 Arg2:T58	
R38	Location_of Arg1:T32 Arg2:T58	
R39	Experiences Arg1:T57 Arg2:T9	
R40	Experiences Arg1:T57 Arg2:T8	
R41	Experiences Arg1:T57 Arg2:T59	
R42	Location_of Arg1:T33 Arg2:T59	
R43	Location_of Arg1:T34 Arg2:T88	
R44	Experiences Arg1:T57 Arg2:T88	
R51	Experiences Arg1:T61 Arg2:T10	
R52	Experiences Arg1:T61 Arg2:T35	
R53	Experiences Arg1:T61 Arg2:T83	
#73	AnnotatorNotes T35	C0271561; Somatotropin deficiency; Disease or Syndrome
R54	Experiences Arg1:T62 Arg2:T40	
R55	Has_Age Arg1:T62 Arg2:T63	
R56	Experiences Arg1:T64 Arg2:T36	
#74	AnnotatorNotes T36	C0271561; Somatotropin deficiency; Disease or Syndrome
R57	Experiences Arg1:T64 Arg2:T38	
T91	Quantifier_or_Qualifier 771 783	al menos una
R58	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T91	
#75	AnnotatorNotes T41	C0271561; Somatotropin deficiency; Disease or Syndrome
R60	Used_for Arg1:T16 Arg2:T44	
R61	Used_for Arg1:T17 Arg2:T44	
T92	CONC 911 915	Pico
#76	AnnotatorNotes T92	C0444505; Peak level; Qualitative Concept
R62	Overlap Arg1:T92 Arg2:T44	
T93	Result_or_Value 984 993	<19 ng/ml
T94	Result_or_Value 1024 1027	<25
R63	Has_Result_or_Value Arg1:T42 Arg2:T94	
T95	Result_or_Value 1029 1038	<11 ng/ml
T96	Result_or_Value 1045 1050	25-30
R64	Has_Result_or_Value Arg1:T43 Arg2:T96	
T97	Result_or_Value 1066 1069	>30
R65	Has_Result_or_Value Arg1:T45 Arg2:T97	
T98	Result_or_Value 1071 1080	< 4 ng/ml
T99	Result_or_Value 1051 1059	<8 ng/ml
T100	CONC 1085 1089	Pico
#77	AnnotatorNotes T100	C0444505; Peak level; Qualitative Concept
R66	Used_for Arg1:T47 Arg2:T19	
T101	Result_or_Value 1138 1147	< 3 ng/ml
R67	Overlap Arg1:T100 Arg2:T19	
R68	Has_Result_or_Value Arg1:T100 Arg2:T101	
T102	Observation 1208 1232	incapacitados legalmente
R69	Has_Quantifier_or_Qualifier Arg1:T68 Arg2:T102	
T103	Observation 1285 1309	participar en el estudio
#78	AnnotatorNotes T103	C1278516; Patient participation status; Finding (?)
R70	Before Arg1:T20 Arg2:T103	
T104	Observation 1339 1363	incapacitados legalmente
R71	Has_Quantifier_or_Qualifier Arg1:T70 Arg2:T104	
T105	Observation 1374 1400	asentimiento en participar
#79	AnnotatorNotes T105	C1302239; Patient consented to clinical trial; Finding (?)
R72	Overlap Arg1:T104 Arg2:T105	
R73	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T65	
T106	Quantifier_or_Qualifier 1689 1695	activo
#80	AnnotatorNotes T106	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R75	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T106	
T107	Quantifier_or_Qualifier 1707 1713	activa
#81	AnnotatorNotes T107	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R76	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T107	
R78	Used_for Arg1:T27 Arg2:T49	
R79	Experiences Arg1:T80 Arg2:T79	
R80	Experiences Arg1:T80 Arg2:T84	
R81	Experiences Arg1:T80 Arg2:T28	
#82	AnnotatorNotes T79	C0559571; At risk; Finding
#83	AnnotatorNotes T44	C0430127; Growth hormone releasing hormone test; Laboratory Procedure
A13	Experiencer T52 Patient
A14	Experiencer T57 Patient
A15	Experiencer T61 Patient
A16	Experiencer T62 Patient
A17	Experiencer T64 Patient
A18	Experiencer T68 Patient
A19	Experiencer T53 Other
A20	Experiencer T70 Patient
A21	Experiencer T77 Patient
A22	Experiencer T78 Other
A23	Experiencer T80 Patient
A24	Assertion T102 Hypothetical
A25	Assertion T104 Hypothetical
